Association between Nrf2, Bcl-2 and Bcl-xL mRNA in lung tumors and tumor response to cisplatin-based chemotherapy in NSCLC patients with tumor recurrence and/or metastasis after surgical resection. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.